Understanding ALS, commonly referred to as Lou Gehrig's disease
-
By
-
Laura Ungar
-
February 20, 2026
By
Laura Ungar
February 20, 2026
by Laura Ungar
February 20, 2026
A four-factor staging system stratified response rates from 90.9% to 37.5% in a retrospective cohort study, although the model showed only moderate discrimination (C statistic, 0.68) and requires external validation
May 8, 2026
Neurologist Michael Todinca, M.D., who specializes in neuromuscular medicine, has joined Baptist Health Miami Neuroscience Institute, part of Baptist Health Brain & Spine Care.
New federal limits on medical school borrowing may quietly reshape who becomes a physician—and where they practice.
by Kerri Miller
April 6, 2026